Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression (Q41095708)

26 September 2017

Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression (English)

1 reference

26 September 2017

0 references

1 reference

Joyce DA

1

1 reference

26 September 2017

Kloda A

series ordinal

2

1 reference

26 September 2017

Steer JH

series ordinal

3

1 reference

26 September 2017

1 August 1997

1 reference

Immunology & Cell Biology

26 September 2017

1 reference

26 September 2017

75

1 reference

26 September 2017

4

1 reference

26 September 2017

345-350

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.1997.53

26 September 2017

0 references

cites work

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1RA by monocytes but augments IL-4-, IL-10-, and TGF-beta-induced suppression of TNF-alpha release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Differential regulation of the macrophage-specific surface antigen RM3/1 by cyclosporine, azathioprine, and dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

A system for assessment of monokine gene expression using human whole blood

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF)

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.53

7 January 2021

Identifiers

DOI

10.1038/ICB.1997.53

1 reference

Dimensions Publication ID

26 September 2017

0 references

1 reference